[Federal Register Volume 75, Number 15 (Monday, January 25, 2010)]
[Notices]
[Pages 3900-3901]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-1314]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Provisional Patent Application Concerning Monoclonal 
Antibodies Against Glycoprotein of Ebola Sudan Boniface Virus

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Announcement is made of the availability for licensing of the 
invention set forth in U.S. Provisional Patent Application Serial No. 
61/290,725 entitled ``Monoclonal Antibodies Against Glycoprotein of 
Ebola Sudan Boniface Virus,'' filed December 29, 2009. The United 
States Government, as represented by the Secretary of the Army, has 
rights to this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, MD 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research and Technology Assessment, (301) 619-6664, 
both at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The invention relates generally to the field 
of

[[Page 3901]]

antibodies. More specifically the invention relates to monoclonal 
antibodies against glycoproteins of the Ebola Sudan Boniface virus and 
methods of producing and using the same.

Brenda S. Bowen,
Army Federal Register Liaison Officer.
[FR Doc. 2010-1314 Filed 1-22-10; 8:45 am]
BILLING CODE 3710-08-P